Pharma tries to recoup public trust

Stung by Public Distrust, Drug Makers Seek to Heal Image: "'The decision against Merck...is a clear statement that despite all the good our industry is doing, we're losing the battle for consumer trust,' says Arthur Higgins, chairman of Bayer Healthcare, a Bayer AG unit."


And they're working on it, but this will be a tough one to come back from—only 21 percent of people surveyed give pharma a favorable rating, according to the article in the Wall St. Journal (free for seven days).

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish